Considering that SWE-assessed liver stiffness is correlated with liver inflammation and hepatic steatosis (30, 31), and is positively correlated with changes in AST, ALT, γ-GTP, body weight and SWV in our study, our results of decreased liver stiffness may partially reflect a pemafibrate-related improvement in liver inflammation and hepatic steatosis. Here, GPT is linked to fatty liver disease.